Výsledky vyhledávání - "Anna B. Moseley"

A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

Publikováno v: Leukemialymphoma.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc71e8c82b561a15cb597ea583e1236a
https://pubmed.ncbi.nlm.nih.gov/36517990

Zobrazit plný text záznamu